ZA953726B - Cyclohexane derivatives process for their preparation and the use of the compounds for the treatment of diseases - Google Patents

Cyclohexane derivatives process for their preparation and the use of the compounds for the treatment of diseases

Info

Publication number
ZA953726B
ZA953726B ZA953726A ZA953726A ZA953726B ZA 953726 B ZA953726 B ZA 953726B ZA 953726 A ZA953726 A ZA 953726A ZA 953726 A ZA953726 A ZA 953726A ZA 953726 B ZA953726 B ZA 953726B
Authority
ZA
South Africa
Prior art keywords
diseases
compounds
preparation
treatment
cyclohexane derivatives
Prior art date
Application number
ZA953726A
Other languages
English (en)
Inventor
Horst Hemmerle
Gerrit Schubert
Hans-Joerg Burger
Andreas Herling
Suad Efendic
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA953726B publication Critical patent/ZA953726B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA953726A 1994-05-10 1995-05-09 Cyclohexane derivatives process for their preparation and the use of the compounds for the treatment of diseases ZA953726B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4416433A DE4416433A1 (de) 1994-05-10 1994-05-10 Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten

Publications (1)

Publication Number Publication Date
ZA953726B true ZA953726B (en) 1996-01-11

Family

ID=6517746

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA953726A ZA953726B (en) 1994-05-10 1995-05-09 Cyclohexane derivatives process for their preparation and the use of the compounds for the treatment of diseases

Country Status (23)

Country Link
US (1) US5739147A (es)
EP (1) EP0682024B1 (es)
JP (1) JP3790564B2 (es)
KR (1) KR100355690B1 (es)
CN (1) CN1043643C (es)
AT (1) ATE187454T1 (es)
AU (1) AU683148B2 (es)
CA (1) CA2149007C (es)
CZ (1) CZ288443B6 (es)
DE (2) DE4416433A1 (es)
DK (1) DK0682024T3 (es)
ES (1) ES2141276T3 (es)
FI (1) FI110097B (es)
GR (1) GR3032519T3 (es)
HK (1) HK1011989A1 (es)
HU (1) HU220865B1 (es)
NO (1) NO304314B1 (es)
NZ (1) NZ272082A (es)
PL (1) PL180074B1 (es)
RU (1) RU2140416C1 (es)
TW (1) TW421648B (es)
UA (1) UA41340C2 (es)
ZA (1) ZA953726B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
ES2433476T3 (es) 2000-01-21 2013-12-11 Novartis Ag Combinaciones que contienen inhibidores de la dipeptidilpeptidasa-IV y agentes 5 antidiabéticos
EP1385549A2 (en) * 2001-03-12 2004-02-04 Novartis AG Combination of nateglinide or repaglinide with at least one further antidiabetic compound
PL1931350T5 (pl) 2005-09-14 2021-11-15 Takeda Pharmaceutical Company Limited Podanie inhibitorów dipeptydylo-peptydazy
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
PT2531501E (pt) 2010-02-03 2014-02-17 Takeda Pharmaceutical Inibidores da cinase de regulação do sinal de apoptose 1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243016A (ja) * 1984-05-17 1985-12-03 Tsumura Juntendo Inc 抗インフルエンザウイルス剤
TW399041B (en) * 1992-09-09 2000-07-21 Hoechst Ag Substituted cyclohexane derivatives, the preparation and the use for treating diseases
TW255880B (es) * 1992-09-09 1995-09-01 Hoechst Ag
DE4408082A1 (de) * 1994-03-10 1995-09-14 Hoechst Ag Substituierte Propan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten
DE4413402A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Herstellung von Zwischenprodukten für die Synthese von Glucose-6-Phosphatase-Inhibitoren sowie neue Zwischenprodukte

Also Published As

Publication number Publication date
FI110097B (fi) 2002-11-29
PL180074B1 (pl) 2000-12-29
AU683148B2 (en) 1997-10-30
RU2140416C1 (ru) 1999-10-27
HK1011989A1 (en) 1999-07-23
EP0682024A1 (de) 1995-11-15
RU95107147A (ru) 1997-03-20
HUT71797A (en) 1996-02-28
NZ272082A (en) 1996-09-25
HU220865B1 (en) 2002-06-29
ATE187454T1 (de) 1999-12-15
PL308521A1 (en) 1995-11-13
TW421648B (en) 2001-02-11
CZ288443B6 (en) 2001-06-13
CZ119595A3 (en) 1995-12-13
CN1118782A (zh) 1996-03-20
NO951820L (no) 1995-11-13
AU1792395A (en) 1995-11-16
FI952203A (fi) 1995-11-11
NO951820D0 (no) 1995-05-09
ES2141276T3 (es) 2000-03-16
NO304314B1 (no) 1998-11-30
CN1043643C (zh) 1999-06-16
DE4416433A1 (de) 1995-11-16
DE59507361D1 (de) 2000-01-13
CA2149007C (en) 2005-07-26
GR3032519T3 (en) 2000-05-31
US5739147A (en) 1998-04-14
KR950032191A (ko) 1995-12-20
EP0682024B1 (de) 1999-12-08
FI952203A0 (fi) 1995-05-08
KR100355690B1 (ko) 2002-12-26
UA41340C2 (uk) 2001-09-17
JPH07330767A (ja) 1995-12-19
CA2149007A1 (en) 1995-11-11
DK0682024T3 (da) 2000-05-22
JP3790564B2 (ja) 2006-06-28

Similar Documents

Publication Publication Date Title
DK0416410T3 (da) Piperaziniocephalosporiner
AU589795B2 (en) New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them
IL115236A0 (en) Tetrahydro-pyridoindole derivatives and pharmaceutcial compositions containing them
PL300327A1 (en) Substituted cycolohexane derivatives, method of obtaining them and application of these compounds in treating diseases
ATE202704T1 (de) Verwendung eines natrium- oder lysiniumsalzes von crotonsäureamidderivaten zur herstellung eines arzneimittels zur behandlung von krebserkrankungen
ZA953726B (en) Cyclohexane derivatives process for their preparation and the use of the compounds for the treatment of diseases
IL119297A (en) 2,3-Dihydroxypropyl-2-(1-oxoalkyl) amino-2-deoxyglucopyranosides a process for their preparation and compositions containing them
ATE100077T1 (de) 2-hydroxy-3-phenoxypropylaminoverbindungen.
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
HUT71511A (en) Piperazine derivatives for producing alkil-trazodone derivatives and process for producing them
DE69232776D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenverbindungen in diesem Verfahren
EP0551844A3 (es)
IT1244649B (it) Procedimento per il trattamento di substrati com composti aromatici contenenti gruppi solfo, composizioni contenenti tali composti e loro preparazione
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
AU8292787A (en) Fluorine-containing macrolide compounds and their use